New Haven, CT, United States of America

Xiuyan Li

This inventor holds 3 USPTO granted patents. Top assignee: Vion Pharmaceuticals, Inc.. Active years: 1998-1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiuyan Li. Retrieved from https://idiyas.com/inventor/xiuyan-li-bvnxfvnt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.3

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 1998-1999

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Xiuyan Li

Introduction

Xiuyan Li is a notable inventor based in New Haven, Connecticut, who has made significant contributions to the field of chemistry. With a total of three patents to his name, he has focused on developing innovative methods for synthesizing complex chemical compounds. His work has implications in pharmaceuticals and biochemistry, showcasing his expertise and dedication to advancing scientific knowledge.

Latest Patents

One of Xiuyan Li's latest patents involves processes for high-yield diastereoselective synthesis. This invention relates to methods for substantially enhancing the stereoselective synthesis of β-anomeric nucleoside analogs. The introduction of a phenylseleno group onto a blocked lactone sugar precursor is a key aspect of this invention. This method allows for the synthesis of nucleoside analogs, particularly 2',3'-dideoxy- and 2',3'-dideoxy-2',3'-didehydronucleoside analogs, in very high yield. In preferred embodiments, the phenylseleno blocked lactone is obtained in amounts representing approximately 90% or more of the total stereoisomers. In even more preferred cases, the amount of the preferred stereoisomer reaches at least 95%, and in some instances, about 97% of the total amount produced.

Another significant patent by Xiuyan Li is focused on the synthesis of ribonucleotide reductase inhibitors, specifically 3-AP. This invention relates to improved and efficient chemical syntheses of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) and 3-amino-4-methylpyridine-2-carboxaldehyde thiosemicarbazone (3-AMP). These advancements are crucial for developing new therapeutic agents.

Career Highlights

Xiuyan Li is currently associated with Vion Pharmaceuticals, Inc., where he continues to contribute to innovative research and development in the pharmaceutical industry. His work is characterized by a commitment to enhancing the efficiency and effectiveness of chemical synthesis processes.

Collaborations

Throughout his career, Xiuyan Li has collaborated with esteemed colleagues, including Shu-Hui Chen and Jun Li. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their research.

Conclusion

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…